Written by Yu-Chuan “Daniel” Lin. Although PrEP medication solves the HIV epidemic, research has found an inadequate number of MSM receiving it. For example, a 2015 U.S. CDC report has indicated that at least one of four gay men should be taking PrEP daily to effectively avoid more extensive HIV transmission, requiring the participation of roughly 1,200,000 MSM nationwide. However, its data showed that no more than 50,000 MSM are doing so, which translates into a poor execution rate (around 3%) of the government’s PrEP project designated to combat the HIV epidemic.
